EFRELand Brandenburgbe Berlin

Medical Technology News

21.04.2017

BIOTRONIK Introduces Smallest MR Conditional Defibrillator Lead in the US

Plexa ProMRI Lead Designed to Improve Durability and Handling.► Read more ...

06.04.2017

RESEARCH 4.0: BERLIN INSTITUTE OF HEALTH MOVES TO ELECTRONIC LAB NOTEBOOKS

Starting in April 2017, the QUEST – Center for Transforming Biomedical Research at Berlin Institute of Health (BIH) will begin to implement electronic lab notebooks to manage research data. All BIH scientists at Charité –...► Read more ...

31.03.2017

WHS Startup Track 2017 Welcomes Applications

International Pitch for Startups in Healthcare at the World Health Summit in Berlin► Read more ...

23.03.2017

Eckert & Ziegler 2016 annual financial statements: Sales and profit according to plan. Gross profit margin up by 6%. Change in the Supervisory Board

Eckert & Ziegler Strahlen- und Medizintechnik AG, a Berlin-based company specializing in isotope technology for medical, scientific and industrial applications, reported sales of € 138.0 million (prior year: € 140.0 million) in...► Read more ...

22.03.2017

Current offers of Charité’s technology transfer office

The technology transfer office of the Charité is a service provider for enterprises and employees of the Charité. They provide advice on issues related to intellectual property rights, they offer consultation on grant...► Read more ...

22.03.2017

Genome Architecture Mapping

The organization of the genome in the nucleus as well as the interactions of genes with their regulatory elements are key features of transcriptional control. Their disruption may cause severe diseases. Technologies based on...► Read more ...

22.03.2017

Novel BCMA-CAR for the treatment of multiple myeloma and non-Hodgkin lymphoma (NHL)

In recent years, BCMA has emerged as an attractive target to treat multiple myeloma (MM). Since BCMA expression is mostly restricted to plasma cells, it is also an exciting target for CAR-T therapy. MM cell lines show an elevated...► Read more ...

22.03.2017

Novel therapeutic strategies in classical Hodgkin's Lymphoma based on restoration of the B-cell phenotype

Classical Hodgkin’s lymphoma (cHL), although occuring as a treatable malignancy with a high likelihood of cure for most patients, reflects a clinical challenge when presented as primary refractory or relapsed disease.► Read more ...

22.03.2017

CURRENT INTERVIEW: DR. IJAD MADISCH, CO-FOUNDER AND CEO OF RESEARCHGATE

The virologist and computer scientist, Dr. Ijad Madisch, has created one of the world’s most important start-ups with ResearchGate – a kind of Facebook for scientists. He founded the Berlin-based online platform 2008 with his...► Read more ...

07.03.2017

PRESS RELEASE: FIVE NEW CHAIRS FOR TRANSLATIONAL MEDICINE AT BERLIN INSTITUTE OF HEALTH

Berlin Institute of Health (BIH) is offering the first chairs who will play a central role at BIH as the founding directors of new centers dedicated to key research areas. Five W3 professorship appointments were announced in the...► Read more ...